Company news
Aurobindo Pharma Ltd (NSE:AUROPHARMA) news
Aurobindo Pharma Ltd news releases on 6ix. Latest, Oct 3, 2026: Aurobindo Pharma Limited has informed the Exchange regarding a press release dated October 03…
Press releases & updates
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated October 03, 2026, titled "Aurobindo Pharma receives USFDA Final Approval for Perampanel Tablets, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg".
October 3, 2026
Aurobindo Pharma Ltd Press Release Sep 30 2026
September 30, 2026
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated September 30, 2026, titled "Acrotech Biopharma Launches ADQUEY in the U.S. and Establishes Dedicated Dermatology Business".
September 30, 2026
Aurobindo Pharma Ltd Press Release Sep 15 2026
September 15, 2026
Aurobindo Pharma Ltd Press Release Aug 31 2026
August 31, 2026
Aurobindo Pharma Ltd Press Release Aug 05 2026
August 5, 2026
Aurobindo Pharma Ltd Press Release Jul 24 2026
July 24, 2026
Aurobindo Pharma Ltd Press Release Jun 22 2026
June 21, 2026
Press Release Jun 04 2026
June 4, 2026
Press Release Jun 03 2026
June 3, 2026
Press Release May 21 2026
May 21, 2026
Press Release Apr 17 2026
April 17, 2026
Press Release Apr 07 2026
April 7, 2026
Press Release Apr 06 2026
April 6, 2026
Press Release Mar 04 2026
March 4, 2026
Press Release Feb 26 2026
February 26, 2026
Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040
February 17, 2026
Press Release Feb 13 2026
February 13, 2026
Press Release Feb 09 2026
February 9, 2026
Kargo.ai Raises $42M Series B to Scale Global Warehouse Deployment with Enterprise Clients
December 22, 2025
Press Release Nov 05 2025
November 5, 2025
Press Release Aug 04 2025
August 4, 2025
Press Release May 26 2025
May 26, 2025
Press Release May 13 2025
May 13, 2025
Press Release Apr 26 2025
April 26, 2025
Press Release Apr 23 2025
April 23, 2025
Press Release Apr 12 2025
April 12, 2025
Press Release Apr 09 2025
April 9, 2025
Press Release Feb 06 2025
February 6, 2025
Press Release Jan 31 2025
January 31, 2025
Press Release Dec 21 2024
December 21, 2024
Press Release Dec 13 2024
December 13, 2024
Press Release Dec 05 2024
December 5, 2024
Aurobindo Pharma : Annual CSR Report 2023-24
November 27, 2024
Press Release Nov 12 2024
November 12, 2024
Aurobindo Pharma : Q2 UFR 2024 25 Corrigendum in Consolidated UFR
November 11, 2024
Press Release Nov 09 2024
November 9, 2024
Aurobindo Pharma : Q2FY25
November 4, 2024
Press Release Oct 29 2024
October 29, 2024
Press Release Oct 01 2024
October 1, 2024
Press Release Aug 10 2024
August 10, 2024
Press Release Aug 06 2024
August 6, 2024
Aurobindo Pharma : Annual Report 2023-24
August 5, 2024
Aurobindo Pharma : Q1FY25
August 5, 2024
Aurobindo Pharma : receives USFDA Approval for Mometasone Furoate Monohydrate Nasal Spray
May 31, 2024
Press Release May 25 2024
May 25, 2024
Aurobindo Pharma : Q4FY24
May 17, 2024
Press Release Mar 19 2024
March 19, 2024
Press Release Mar 15 2024
March 15, 2024
Press Release Mar 01 2024
March 1, 2024